Literature DB >> 20814942

Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood.

Madeleine Rådinger1, Bettina M Jensen, Hye Sun Kuehn, Arnold Kirshenbaum, Alasdair M Gilfillan.   

Abstract

Antigen-mediated mast cell activation is a pivotal step in the initiation of allergic disorders including anaphylaxis and atopy. To date, studies aimed at investigating the mechanisms regulating these responses, and studies designed to identify potential ways to prevent them, have primarily been conducted in rodent mast cells. However, to understand how these responses pertain to human disease, and to investigate and develop novel therapies for the treatment of human mast cell-driven disease, human mast cell models may have greater relevance. Recently, a number of systems have been developed to allow investigators to readily obtain sufficient quantities of human mast cells to conduct these studies. These mast cells release the appropriate suite of inflammatory mediators in response to known mast cell activators including antigen. These systems have also been employed to examine the signaling events regulating these responses. Proof of principle studies has also demonstrated utility of these systems for the identification of potential inhibitors of mast cell activation and growth. In this unit, techniques for the development and culture of human mast cells from their progenitors and the culture of human mast cell lines are described. The relative merits and drawbacks of each model are also described. 2010 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20814942      PMCID: PMC2923748          DOI: 10.1002/0471142735.im0737s90

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  18 in total

Review 1.  Mast cells in innate immunity.

Authors:  Y A Mekori; D D Metcalfe
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

Review 2.  New developments in FcepsilonRI regulation, function and inhibition.

Authors:  Stefan Kraft; Jean-Pierre Kinet
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 3.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

Review 4.  Mast cells and mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

Review 5.  Mast cells.

Authors:  D D Metcalfe; D Baram; Y A Mekori
Journal:  Physiol Rev       Date:  1997-10       Impact factor: 37.312

6.  Establishment of an immature mast cell line from a patient with mast cell leukemia.

Authors:  J H Butterfield; D Weiler; G Dewald; G J Gleich
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

7.  Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13).

Authors:  A S Kirshenbaum; J P Goff; T Semere; B Foster; L M Scott; D D Metcalfe
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

8.  Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells.

Authors:  Hanne Busk Andersen; Mette Holm; Thea Eline Hetland; Christine Dahl; Steffen Junker; Peter Oluf Schiøtz; Hans Jürgen Hoffmann
Journal:  J Immunol Methods       Date:  2008-05-16       Impact factor: 2.303

9.  Seven week culture of functional human mast cells from buffy coat preparations.

Authors:  Mette Holm; Hanne Busk Andersen; Thea Eline Hetland; Christine Dahl; Hans Jürgen Hoffmann; Steffen Junker; Peter Oluf Schiøtz
Journal:  J Immunol Methods       Date:  2008-05-27       Impact factor: 2.303

10.  Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.

Authors:  Arnold S Kirshenbaum; Cem Akin; Yalin Wu; Menachem Rottem; Julie P Goff; Michael A Beaven; V Koneti Rao; Dean D Metcalfe
Journal:  Leuk Res       Date:  2003-08       Impact factor: 3.156

View more
  40 in total

1.  Providing the TORC for cell cycle progression in neoplastic mast cells.

Authors:  Daniel Smrž; Todd M Wilson; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

2.  CD84 negatively regulates IgE high-affinity receptor signaling in human mast cells.

Authors:  Damiana Álvarez-Errico; Irene Oliver-Vila; Erola Ainsua-Enrich; Alasdair M Gilfillan; César Picado; Joan Sayós; Margarita Martín
Journal:  J Immunol       Date:  2011-11-07       Impact factor: 5.422

3.  Mast Cell Degranulation and Fibroblast Activation in the Morphine-induced Spinal Mass: Role of Mas-related G Protein-coupled Receptor Signaling.

Authors:  Tony L Yaksh; Kelly A Eddinger; Shinichi Kokubu; Zhenping Wang; Anna DiNardo; Roshni Ramachandran; Yuelian Zhu; Yajun He; Fieke Weren; Daphne Quang; Shelle A Malkmus; Katherine Lansu; Wesley K Kroeze; Brian Eliceiri; Joanne J Steinauer; Peter W Schiller; Peter Gmeiner; Linda M Page; Keith R Hildebrand
Journal:  Anesthesiology       Date:  2019-07       Impact factor: 7.892

4.  The transcription factors GATA2 and microphthalmia-associated transcription factor regulate Hdc gene expression in mast cells and are required for IgE/mast cell-mediated anaphylaxis.

Authors:  Yapeng Li; Bing Liu; Laura Harmacek; Zijie Long; Jinyi Liang; Kara Lukin; Sonia M Leach; Brian O'Connor; Anthony N Gerber; James Hagman; Axel Roers; Fred D Finkelman; Hua Huang
Journal:  J Allergy Clin Immunol       Date:  2017-12-24       Impact factor: 10.793

5.  An optimized protocol for the generation and functional analysis of human mast cells from CD34+ enriched cell populations.

Authors:  Yuzhi Yin; Yun Bai; Ana Olivera; Avanti Desai; Dean D Metcalfe
Journal:  J Immunol Methods       Date:  2017-06-16       Impact factor: 2.303

6.  Imatinib in pulmonary arterial hypertension: c-Kit inhibition.

Authors:  Samar Farha; Raed Dweik; Franck Rahaghi; Raymond Benza; Paul Hassoun; Robert Frantz; Fernando Torres; Deborah A Quinn; Suzy Comhair; Serpil Erzurum; Kewal Asosingh
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

7.  PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells.

Authors:  Hariharan Subramanian; Sakeen W Kashem; Sarah J Collington; Hongchang Qu; John D Lambris; Hydar Ali
Journal:  Mol Pharmacol       Date:  2011-03-11       Impact factor: 4.436

8.  Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype.

Authors:  Eunice Ching Chan; Yun Bai; Arnold S Kirshenbaum; Elizabeth R Fischer; Olga Simakova; Geethani Bandara; Linda M Scott; Laura B Wisch; Daly Cantave; Melody C Carter; John C Lewis; Pierre Noel; Irina Maric; Alasdair M Gilfillan; Dean D Metcalfe; Todd M Wilson
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

9.  Mast cell isolation from the immature rat brain.

Authors:  Shyama D Patel; Gillian Brennan; Jacqueline Brazin; Amber J Ciardiello; Randi B Silver; Susan J Vannucci
Journal:  Dev Neurosci       Date:  2013-05-25       Impact factor: 2.984

10.  Knockout of the Trpc1 gene reveals that TRPC1 can promote recovery from anaphylaxis by negatively regulating mast cell TNF-α production.

Authors:  Nevenka Medic; Avanti Desai; Ana Olivera; Joel Abramowitz; Lutz Birnbaumer; Michael A Beaven; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Cell Calcium       Date:  2013-03-13       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.